Kick off the Integrative Healthcare Symposium (IHS) with the preconference event Coronary Artery Disease: Clinical Insight into a Silent Killer hosted by Metagenics Institute in collaboration with Mark Houston, MD.

This symposium unites healthcare practitioners from all backgrounds. Whether you have a traditional or nontraditional medical practice, you will walk away with an enhanced understanding and appreciation for approaching patient health through an integrative lens.

While the symposium has a wide array of educational sessions, this preconference by Metagenics Institute will provide clinicians insight and clinical pearls into cardiovascular health.

Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 31% of all deaths. In the United States, coronary artery disease is the most prevalent form of cardiovascular disease. Dr. Houston, a leading cardiovascular and hypertension specialist will be featured in numerous lectures and panels during the preconference event accompanied by other distinguished physicians, including Sara Gottfried, MD and Michael Conte, MD.

This day-long event will cover:

Metagenics Institute and Mark Houston, MDCoronary Artery Disease: Clinical Insight into a Silent Killer

Date: Wednesday, February 19, 2020 • Hotel location: New York Hilton Midtown, NY

Register for the preconference: http://bit.ly/MetagenicsInstituteatIHS

Register for IHS conference: https://www.ihsymposium.com/register/

• Diagnosis, prevention, and treatment of

cardiovascular disease

• Vascular systems biology and dyslipidemia

• Advanced lipid testing

• Sex differences in heart health

• Underlying causes of dyslipidemia

• The role of personalized lifestyle medicine for

cardiovascular disease

So get ready to pack your bags and join us in New York on Wednesday, February 19, 2020, for this preconference event and get to the heart of the matter of coronary artery disease.

Join us at the IHS preconference event in New York

Get to the Heart of the Matter

IHS Preconference Event Agenda

Time Speaker Topic

8:15 AM–9:00 AM Mark Houston, MD Vascular Systems Biology: Define the Relationships of the Finite Vascular Responses to the “Infinite” Range of Vascular Insults

9:00 AM–9:45 AM Michael Conte, MDInflammation Resolution and Vascular Biology and Development of Atherosclerosis/SPM Supplementation in PAD Patients

9:45 AM–10:00 AM Q&A

10:00 AM–10:15 AM Break

10:15 AM–11:00 AM Mark Houston, MDAssess Underlying Causes of Dyslipidemia Such as Toxins, Infections, and Nutrition as Well as Secondary Causes

11:00 AM–12:30 PM

Jeff Volek, PhD Mimi Guarneri, MD Mark Houston, MD

Sara Gottfried, MD

What Is the Best Diet for the Heart? A panel discussion with experts in the field. A review of the pros and cons of different dietary options based on research and clinical experience from the perspectives of Jeff Volek, PhD, Mimi Guarneri, MD, and Mark Houston, MD. Moderated by Sara Gottfried, MD.

12:30 PM–1:30 PM Lunch

1:30 PM–2:15 PM Sara Gottfried, MD Sex Differences in the Heart

2:15 PM–2:45 PM Mark Houston, MD How to Order and Interpret Advanced Lipid Testing: an Interview with Mark Houston, MD

2:45 PM–3:00 PM Q&A

3:00 PM–3:15 PM Break

3:15 PM–4:00 PM Mark Houston, MD HDL Function: A Wolf in Sheep’s’ Clothing

4:00 PM–5:00 PM Bringing It All Together: Case study discussion

MET2995 012320 © 2020 Metagenics Institute. All Rights Reserved.

Mark Houston, MD, MS, FAHA, FASH, DABC is a highly recognized cardiovascular and hypertension specialist, serving as a physician at St. Thomas West Hospital in Nashville, where he holds several leadership positions including Director of the Hypertension Institute and Vascular Biology, Medical Director of Clinical Research, and Section Chief for the Division of Nutrition. Dr. Houston cofounded the Hypertension Institute, which is one of the leading institutes in the US for hypertension treatment. An American Society of Hypertension (ASH) specialist and Diplomate of the American Board of Cardiology, Dr. Houston is also a Fellow of the American Society of Hypertension (FASH), the American Heart Association (FAHA), Internal Medicine (ABIM), American College of Nutrition (FACN) and Anti-Aging Medicine (ABAARM). Dr. Houston received his medical degree from Vanderbilt University. He also obtained two master’s degrees, in Human Nutrition and Metabolic Medicine and Human Nutrition, from the University of Bridgeport and University of South Florida, respectively.